West Pharmaceutical
About: West Pharmaceutical Services is based in Pennsylvania, U.S., and is a key supplier to firms in the pharmaceutical, biotechnology, and generic drug industries. West sells elastomer-based packaging components (including stoppers, seals, and plungers), non-glass containment solutions, and auto-injectors for injectable drugs. The company reports in two segments: proprietary products (about 80% of total revenue) and contract-manufactured products (about 20% of total revenue). It generates approximately 55% of its revenue from international markets and 45% from the United States.
Employees: 10,600
Fund manager confidence
Based on 2024 Q2 SEC filings by fund managers ($100M+ AUM)
43% more call options, than puts
Call options by funds: $148M | Put options by funds: $104M
0.49% more ownership
Funds ownership: 93.34% [Q1] → 93.83% (+0.49%) [Q2]
0% more funds holding
Funds holding: 768 [Q1] → 768 (+0) [Q2]
0% more first-time investments, than exits
New positions opened: 86 | Existing positions closed: 86
6% less repeat investments, than reductions
Existing positions increased: 275 | Existing positions reduced: 292
17% less capital invested
Capital invested by funds: $27B [Q1] → $22.4B (-$4.51B) [Q2]
67% less funds holding in top 10
Funds holding in top 10: 9 [Q1] → 3 (-6) [Q2]
Research analyst outlook
We haven’t received any recent analyst ratings for WST.
Financial journalist opinion
Based on 5 articles about WST published over the past 30 days